CORC

浏览/检索结果: 共6条,第1-6条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Efficacy and safety of tadalafil 5 mg once-daily in Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction: A phase 3, randomized, double-blind, parallel, placebo- and tamsulosin-con 期刊论文
2019, 卷号: 26, 期号: 2, 页码: 192-200
作者:  Zhang, Zhichao;  Li, Hanzhong;  Zhang, Xiaodong;  Dai, Yutian;  Park, Hyun Jun
收藏  |  浏览/下载:13/0  |  提交时间:2020/01/03
Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China A Randomized Clinical Trial 期刊论文
2019, 卷号: 4, 期号: 5, 页码: 418-427
作者:  Wu, Yangfeng;  Li, Shenshen;  Patel, Anushka;  Li, Xian;  Du, Xin
收藏  |  浏览/下载:219/0  |  提交时间:2020/01/03
"他达拉非5mg每日一次治疗勃起功能障碍"中国专家共识 期刊论文
2018, 卷号: 32, 期号: 1, 页码: 57-62,72
作者:  姜辉;  邓春华;  商学军;  张志超;  戴玉田
收藏  |  浏览/下载:24/0  |  提交时间:2020/01/03
Evaluation of the long-term safety and effectiveness of tadalafil once daily in Chinese men with erectile dysfunction: interim results of a multicenter, randomized,open-label trial 期刊论文
2018, 卷号: 20, 期号: 6, 页码: 587-592
作者:  Jiang Hui;  Zhao Lianming;  Lin Haocheng;  Yan Su;  Liu Jihong
收藏  |  浏览/下载:17/0  |  提交时间:2020/01/03
An open-label, multicenter, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in Chinese men naive to phosphodiesterase 5 inhibitor therapy 期刊论文
2015, 卷号: 17, 期号: 1, 页码: 61-67
作者:  Bai Wenjun;  Li Hongjun;  Dai Yutian;  He Xueyou;  Huang Yiran
收藏  |  浏览/下载:8/0  |  提交时间:2020/01/04
中国男性勃起功能障碍患者首次接受磷酸二酯酶5抑制剂治疗的开放、多中心、随机交叉性研究--比较西地那非和他达拉非治疗的不同 会议论文
2013北京泌尿外科学术年会, 北京, 2013-07-01
作者:  何学酉;  顾民;  邓庶民;  方家杰;  SORSABURA SEBASTIAN
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace